Benefits and Risks – Reveal® XT Insertable Cardiac Monitor

Your doctor may not been able to diagnose your heart symptoms using traditional methods. Or, your doctor may not be certain what kind of treatment will be best for you. In these cases, an insertable cardiac monitor may provide the answers.


There are several benefits from using the Reveal XT Insertable Cardiac Monitor:

  • A diagnosis is more likely to be made than using traditional methods1
  • The device can help your doctor decide on the best treatment for you; this is based on information the monitor records about your heart rhythms
  • Your doctor will be able to see how treatments are affecting your heart rhythms
  • The Reveal XT is not like other types of heart monitors that are attached on the outside of your body for 2 to 60 days. This insertable cardiac monitor is designed for long-term use. The Reveal XT monitors your heart rhythms 24 hours a day, every day for up to three years
  • Because the cardiac monitor is placed under the skin, you do not have to use sticky recording pads on your body or worry about connecting any wires
  • The data recorded is not influenced by restrictions in activities as might be the case with monitors that are worn outside the body. You can continue your regular activities and the monitor will record real-life, relevant information.


As with any medical treatment, some people may experience side effects. Because the cardiac monitor is implanted just beneath the skin, there is a slight risk of infection, the device moving or coming through the skin, and/or sensitivity to the cardiac monitor material. However, the number of people who experience these problems is very low. The Reveal XT Insertable Cardiac Monitor is prescribed by your physician. This device is not for everyone. Please talk to your doctor to see if it is right for you. Your physician should discuss all potential benefits and risks with you. Although many patients benefit from the use of this treatment, results may vary.


  1. Botto GL, Padeletti L, Santini M et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009; 20: 241–8.

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.

Last updated: 22 Sep 2010

Section Navigation

Additional information

Take Charge

Contact Us

Medtronic Limited
Building 9
Croxley Green Business Park
Hatters Lane
Watford, Hertfordshire
WD18 8WW
work Tel. +44 (0)1923 212213
work Fax +44 (0)1923 241004
United Kingdom